E. Jabbour, H. Kantarjian, D. Jones, et al. Long-term incidence and outcome of BCR-ABL mutations in patients (pts) with chronic myeloid leukemia (CML) treated with imatinib mesylate: P-loop mutations are not associated with worse outcome. Blood, 2004, 104: 288a.

伊马替尼和尼洛替尼治疗慢性粒细胞白血病的疗效比较研究
Observation of Imatinib and Nilotinib in the Treatment of Chronic Myeloid Leukemia

王宇瑶, 杨 洁, 李 杰, 王瑞仓, 袁 军, 李 燕, 张晓霞, 郝洪岭   

世界肿瘤研究Vol.9 No.2, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2019.92010, April 9 2019

慢性髓细胞白血病对伊马替尼产生耐药性的机制
Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

夏君燕, 朱 平   

世界肿瘤研究Vol.2 No.3, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2012.23003, July 26 2012

BCR-ABL阴性的MPN的研究进展
Research Progress of BCR-ABL Negative MPN

杜杰鑫, 耿 惠   

临床医学进展Vol.12 No.9, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1291201, September 13 2022

达沙替尼治疗儿童慢性粒细胞白血病的进展分析
Analysis of the Progress of Dasatinib in the Treatment of Chronic Myeloid Leukemia in Children

覃 欢, 于 洁   

临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112918, December 31 2021

博舒替尼治疗慢性粒细胞白血病现状
Current Situation of Bosutinib in the Treatment of Chronic Myeloid Leukemia

余艳玲, 余 涛, 余 甜, 万茜茜   

临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131014, January 6 2023

81例Ph染色体阳性急性淋巴细胞白血病患者的遗传学特征及疗效分析
Genetic Characteristics and Curative Effect Analysis of 81 Patients with Ph Chromosome Positive Acute Lymphoblastic Leukemia

孔 琦, 赵春亭, 崔渤莉, 王彩曌, 闫思琪, 费海荣, 李田兰, 刘珊珊   

临床医学进展Vol.10 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2020.1011426, November 30 2020